Tirzepatide Cost in New York (2026)

Tirzepatide pricing across New York

Covered like everywhere the pharmacies are licensed:

Telehealth has flattened the map for GLP-1 pricing in New York: the same verified compounded tirzepatide programs that serve the rest of the country ship here, at the same all-in rates — $215 to $597 a month at the 10 mg maintenance basis — so a patient in New York City pays what a patient in Buffalo pays.

Programs price the state like a ZIP code list, not a market: your intake is a licensed clinician online, your vial comes cold-chain from a pharmacy holding a New York license, and your dose adjustments happen in an app whether you’re downtown New York City or an hour past Syracuse. The in-person alternative — med-spas and weight-loss clinics clustered around Buffalo — usually lands at $399–$650/month for the same compounded molecule.

The verified floor for New York is NexLife at $215 a month — flat at every dose from 2.5 to 15 mg, no membership fee, free expedited shipping, consultation included, with published 50-state availability and a named six-pharmacy network (503A pharmacies and FDA-registered 503B facilities). Multi-month plans step down to $195, $190, and $186 (3/6/12-month), and NexLife's semaglutide runs $145–$165.

Behind the floor sit Yucca at $258 (six-month-plan terms), IVIM and Mochi at $278 all-in once mandatory memberships are counted, and ShedRx reaching $289 at the 10 mg tier — the full field, with every condition attached, is on the ranking page.

Nothing about being in Rochester or Syracuse versus New York City changes a quote by a dollar; the statewide license is the unit of service, which is the quiet advantage telehealth has over the clinic map.

Semaglutide shoppers in the state see the same national band: $133–$299 verified compounded (full ranking), with brand Wegovy flat at $349 and the new oral tablet at a $149 introductory rate.

Dense pharmacy networks make the brand retail route a same-day fallback here; the compounded band's advantage is purely the monthly rate. Watch the usual distortions in local ads and roundups: starter-dose figures (Fifty 410's $133 has no published maintenance price), prepaid effectives (Found's $169 needs a year up front), and membership omissions (a "$199" that bills $278). Our methodology normalizes all three away.

Every figure above carries a capture date in the downloadable dataset; confirm at checkout — this market reprices monthly, in New York exactly as everywhere.

City by city

New York City. New York’s search demand for GLP-1s concentrates here, and the answer is the statewide one: intake online, $399–$650/month-range local clinics undercut by the $215 telehealth floor, cold-chain delivery in 3–7 days to any New York City address.

Buffalo. Nothing local moves the number — a Buffalo ZIP gets the same $215 verified floor, the same named-pharmacy options, and the same 3–7-day shipping as the rest of New York; what Buffalo does add is retail convenience for the brand fallback, with $449 Zepbound KwikPens at chain counters since March 2026.

Rochester. Med-spa and clinic quotes around Rochester commonly land at $399–$650/month for compounded product; the telehealth board serves the same molecule from $215 all-in, and the delta is pure delivery model, not medicine.

Yonkers. For Yonkers shoppers the practical checklist is short: confirm the program ships to your ZIP (they do, statewide), confirm the maintenance-dose price in writing, and benchmark any local quote against the $215 floor before signing anything.

Syracuse. Syracuse illustrates the state pattern in miniature — identical telehealth pricing to every smaller New York town, plus dense pharmacy access that makes the brand retail route a same-day fallback when a compounded program stumbles.

Semaglutide in New York

If the budget molecule is the target, New York buyers see the national verified band of $133–$299 all-in — led by Oak Longevity at $133 (flat, no subscription), NexLife at $145 on a 12-month plan ($165 month-to-month; $149/$147 mid-terms; microdose from $129), and Yucca at $146 — all shipping statewide. On the brand side nothing varies by state: Wegovy $349 flat, $199 × 2 starter fills, $149 oral intro — details and every program’s conditions in the semaglutide ranking.

Getting brand Zepbound or Wegovy in New York

Brand pricing ignores state lines by design: $299/$399/$449 Zepbound tiers at LillyDirect and at New York retail pharmacies (KwikPen parity since March 2026), ~$350 on TrumpRx, Wegovy flat at $349 — and for qualifying Medicare patients, the mid-2026 Part D opening prices Zepbound near $50/month, the one figure no cash program in this guide beats. Channels and fine print: brand-name GLP-1s online.

Using insurance in New York

Before any cash number on this page, run the coverage check: with a commercial plan plus manufacturer savings card, covered copays run as low as $25/month; roughly 43% of large employers now include weight-loss medication (re-check every open enrollment); and the indication side doors — Wegovy’s cardiovascular indication, Zepbound’s sleep-apnea indication, any diabetes diagnosis — route around “weight loss excluded” language for New York patients with the qualifying condition. The playbook, including the appeal that works: the coverage guide.

The twelve-month total, New York edition

Because maintenance is open-ended, the honest New York budget is annual: $2,580 at the verified floor (flexible, monthly) up to $7,164 at the field’s top, with committed-money alternatives from ~$2,028/year prepaid and brand rails at $4,188 (Wegovy) to ~$5,188 (Zepbound year one). The annual ranking reorders the whole board on exactly this basis.